Dentons US LLP
03/03/2026 | Press release | Distributed by Public on 03/03/2026 10:29
Dentons Advises Immunic, Inc. on Private Placement and Royalty Transactions
March 3, 2026
Dentons advised Immunic, Inc. on its private placement financing of up to US$400 million, including US$200 million in initial proceeds and the potential for an additional US$200 million.
The financing is expected to support the completion of Immunic's Phase III clinical trials and its transition to a commercial organization, advancing the company's long-term growth and strategic objectives.
Dentons was pleased to support Immunic on these transactions with a Venture Technology team led by Ilan Katz, Grant Levine, Zachary Weiss, and Madeline Hunter in New York.
About Dentons
Redefining possibilities. Together, everywhere. For more information visit dentons.com
Dentons US LLP published this content on March 03, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 03, 2026 at 16:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]